Search

Author/Creator Manos, Michael

1. 648 Cytokine changes during immune-related adverse events and steroid treatment in melanoma patients receiving immune checkpoint inhibitors. (9th November 2020)

Authors:
Tyan, Kevin; Baginska, Joanna; Brainard, Martha; Giobbie-Hurder, Anita; Severgnini, Mariano; Manos, Michael; Haq, Rizwan; Buchbinder, Elizabeth; Ott, Patrick; Stephen Hodi, F; Rahma, Osama
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors. (10th December 2020)

Authors:
Tyan, Kevin; Bui, Ai-Tram; Giobbie-Hurder, Anita; Klein, Isaac; Manos, Michael; Zubiri, Leyre; Reynolds, Kerry; Grover, Shilpa; Weinhouse, Gerald; Ott, Patrick; LeBoeuf, Nicole; Rahma, Osama
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors. (9th November 2020)

Authors:
Tyan, Kevin; Bui, Ai-Tram; Giobbie-Hurder, Anita; Klein, Isaac; Manos, Michael; Zubiri, Leyre; Reynolds, Kerry; Grover, Shilpa; Weinhouse, Gerald; Ott, Patrick; LeBoeuf, Nicole; Rahma, Osama
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A515
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Issue 1 (6th March 2018)

Authors:
Subrahmanyam, Priyanka B.; Dong, Zhiwan; Gusenleitner, Daniel; Giobbie-Hurder, Anita; Severgnini, Mariano; Zhou, Jun; Manos, Michael; Eastman, Lauren M.; Maecker, Holden T.; Hodi, F. Stephen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. (15th March 2021)

Authors:
Buchbinder, Elizabeth I.; Weirather, Jason L.; Manos, Michael; Quattrochi, Brian J.; Sholl, Lynette M.; Brennick, Ryan C.; Bowling, Peter; Bailey, Nancy; Magarace, Lisa; Ott, Patrick A.; Haq, Rizwan; Izar, Benjamin; Giobbie‐Hurder, Anita; Hodi, F. Stephen
Journal:
Cancer medicine
Issue:
Volume 10:Number 8(2021)
Page Start:
2627
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Issue 1 (19th January 2021)

Authors:
Rogiers, Aljosja; Pires da Silva, Ines; Tentori, Chiara; Tondini, Carlo Alberto; Grimes, Joseph M; Trager, Megan H; Nahm, Sharon; Zubiri, Leyre; Manos, Michael; Bowling, Peter; Elkrief, Arielle; Papneja, Neha; Vitale, Maria Grazia; Rose, April A N; Borgers, Jessica S W; Roy, Severine; Mangana, Jo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor‐induced colitis. Issue 16 (22nd June 2020)

Authors:
Grover, Shilpa; Dougan, Michael; Tyan, Kevin; Giobbie‐Hurder, Anita; Blum, Steven M.; Ishizuka, Jeffrey; Qazi, Taha; Elias, Rawad; Vora, Kruti B.; Ruan, Alex B.; Martin‐Doyle, William; Manos, Michael; Eastman, Lauren; Davis, Meredith; Gargano, Maria; Haq, Rizwan; Buchbinder, Elizabeth I.; Sulliva...
Journal:
Cancer
Issue:
Volume 126:Issue 16(2020)
Page Start:
3758
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service. Issue 2 (18th August 2020)

Authors:
Abu-Shawer, Osama; Singh, Prabhsimranjot; Yenulevich, Eric; Brito, Amanda; Ni, Jian; Abdulnour, Raja-Elie E; Grover, Shilpa; Manos, Michael; Bowling, Peter; LeBoeuf, Nicole R; Ott, Patrick; Stephen Hodi, F; Jacobson, Joseph; Rahma, Osama
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features. Issue 1 (24th April 2019)

Authors:
Schoenfeld, Jonathan D.; Nishino, Mizuki; Severgnini, Mariano; Manos, Michael; Mak, Raymond H.; Hodi, F. Stephen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 808 Exploring resistance mechanism to pembrolizumab and ang-2 inhibitor trebananib (NCT03239145) using high-dimensional single-cell mass cytometry (CyTOF). (10th December 2020)

Authors:
Rahma, Osama; Baginska, Joanna; Brainard, Martha; Giobbie-Hurder, Anita; Tyan, Kevin; Cleary, James; Schlechter, Benjamin; Maloney, Anna; Manos, Michael; Romee, Rizwan; Severgnini, Mariano; Stephen Hodi, F
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A483
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗